APA

van Kooten H. A., Harlaar L., van der Beek N. A. M. E., van Doorn P. A., van der Ploeg A. T. & Brusse E. (20210104). Discontinuation of enzyme replacement therapy in adults with Pompe disease: Evaluating the European POmpe Consortium stop criteria. : Neuromuscular disorders : NMD.

Chicago

van Kooten H A, Harlaar L, van der Beek N A M E, van Doorn P A, van der Ploeg A T and Brusse E. 20210104. Discontinuation of enzyme replacement therapy in adults with Pompe disease: Evaluating the European POmpe Consortium stop criteria. : Neuromuscular disorders : NMD.

Harvard

van Kooten H. A., Harlaar L., van der Beek N. A. M. E., van Doorn P. A., van der Ploeg A. T. and Brusse E. (20210104). Discontinuation of enzyme replacement therapy in adults with Pompe disease: Evaluating the European POmpe Consortium stop criteria. : Neuromuscular disorders : NMD.

MLA

van Kooten H A, Harlaar L, van der Beek N A M E, van Doorn P A, van der Ploeg A T and Brusse E. Discontinuation of enzyme replacement therapy in adults with Pompe disease: Evaluating the European POmpe Consortium stop criteria. : Neuromuscular disorders : NMD. 20210104.